1. Home
  2. CNTA vs CMPR Comparison

CNTA vs CMPR Comparison

Compare CNTA & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • CMPR
  • Stock Information
  • Founded
  • CNTA 2020
  • CMPR 1994
  • Country
  • CNTA United Kingdom
  • CMPR Ireland
  • Employees
  • CNTA N/A
  • CMPR N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • CMPR Publishing
  • Sector
  • CNTA Health Care
  • CMPR Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • CMPR Nasdaq
  • Market Cap
  • CNTA 2.2B
  • CMPR 2.0B
  • IPO Year
  • CNTA 2021
  • CMPR N/A
  • Fundamental
  • Price
  • CNTA $18.19
  • CMPR $81.25
  • Analyst Decision
  • CNTA Strong Buy
  • CMPR Strong Buy
  • Analyst Count
  • CNTA 7
  • CMPR 2
  • Target Price
  • CNTA $23.71
  • CMPR $114.50
  • AVG Volume (30 Days)
  • CNTA 527.9K
  • CMPR 160.8K
  • Earning Date
  • CNTA 11-12-2024
  • CMPR 10-30-2024
  • Dividend Yield
  • CNTA N/A
  • CMPR N/A
  • EPS Growth
  • CNTA N/A
  • CMPR N/A
  • EPS
  • CNTA N/A
  • CMPR 5.90
  • Revenue
  • CNTA $6,853,000.00
  • CMPR $3,339,531,000.00
  • Revenue This Year
  • CNTA N/A
  • CMPR $7.63
  • Revenue Next Year
  • CNTA N/A
  • CMPR $5.45
  • P/E Ratio
  • CNTA N/A
  • CMPR $13.51
  • Revenue Growth
  • CNTA N/A
  • CMPR 6.57
  • 52 Week Low
  • CNTA $5.58
  • CMPR $58.05
  • 52 Week High
  • CNTA $18.74
  • CMPR $104.92
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 64.61
  • CMPR 55.54
  • Support Level
  • CNTA $15.00
  • CMPR $75.55
  • Resistance Level
  • CNTA $18.74
  • CMPR $83.04
  • Average True Range (ATR)
  • CNTA 1.18
  • CMPR 3.04
  • MACD
  • CNTA 0.10
  • CMPR 0.39
  • Stochastic Oscillator
  • CNTA 85.29
  • CMPR 84.67

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About CMPR Cimpress plc (Ireland)

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

Share on Social Networks: